The endometrium in adenomyosis

Women's Health

Volumn 8, Issue 3, 2012, Pages 301-312

  Benagiano, Giuseppe ^a   Brosens, Ivo ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b LEUVEN INSTITUTE FOR FERTILITY AND EMBRYOLOGY   (Belgium)

Author keywords

abnormal uterine bleeding; adenomyosis; dysmenorrhea; ectopic endometrium; eutopic endometrium; hysterectomy; infertility; pathogenesis

Indexed keywords

AROMATASE; CATALASE; CD3 ANTIGEN; CYCLOOXYGENASE 2; ESTROGEN RECEPTOR; GAMMA INTERFERON; GESTAGEN; GLUTATHIONE PEROXIDASE; GONADORELIN AGONIST; GONADORELIN RECEPTOR; HLA ANTIGEN; HLA DR ANTIGEN; OXYTOCIN RECEPTOR; PROGESTERONE; PROGESTERONE RECEPTOR; PROGESTERONE RECEPTOR B; PROTEIN BCL 2; PROTEIN P50; PROTEIN P52; REACTIVE OXYGEN METABOLITE; ROUNDABOUT RECEPTOR; SLIT PROTEIN; SUPEROXIDE DISMUTASE; SYNAPTOTAGMIN I; UVOMORULIN; VANILLOID RECEPTOR 1; VERY LATE ACTIVATION ANTIGEN 2; VERY LATE ACTIVATION ANTIGEN 3; XANTHINE OXIDASE;

ADENOMYOSIS; ANGIOGENESIS; APOPTOSIS; CELL PROLIFERATION; CYTOKINE PRODUCTION; ENDOMETRIAL DISEASE; ENDOMETRIOSIS; ENDOMETRIUM; EPITHELIAL MESENCHYMAL TRANSITION; GAMMA DELTA T LYMPHOCYTE; HUMAN; IMMUNE RESPONSE; IMMUNOLOGY; INNERVATION; NONHUMAN; ORAL CONTRACEPTION; PATHOGENESIS; PROTEIN EXPRESSION; REVIEW; STEROIDOGENESIS; T LYMPHOCYTE ACTIVATION; UTERINE INNERVATION;

ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMANS;

EID: 84860565154     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.12.8     Document Type: Review

References (62)

1. Vinatier D, Cosson M, Dufour P. Is endometriosis an endometrial disease? Eur. J. Obstet. Gynecol. Reprod. Biol. 91, 113-125 (2000)
2. Sharpe-Timms KL. Endometrial anomalies in women with endometriosis. Ann. N. Y. Acad. Sci. 943, 131-147 (2001)
3. Carvalho L, Podgaec S, Bellodi-Privato M, Falcone T, Abrao MS. Role of eutopic endometrium in pelvic endometriosis. J. Minim. Invasive Gynecol. 18, 419-427 (2011)
4. Brosens I, Brosens JJ, Benagiano G. The eutopic endometrium in endometriosis: Are the changes of clinical significance? Repro. BioMed. Online doi:10.1016/j.rbmo.2012.01.022 (2012) (Epub ahead of print)
5. Brosens JJ, De Souza NM, Barker FG. Uterine junctional zone: Function and disease. Lancet 346, 558-560 (1995)
6. De Souza NM, Brosens JJ, Schwieso JE, Paraschos T, Winston RM. The potential value of magnetic resonance imaging in infertility. Clin. Radiol. 50, 75-79 (1995)
7. Larsen SB, Lundorf E, Forman A, Dueholm M. Adenomyosis and junctional zone changes in patients with endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 157, 206-211 (2011)
8. Kunz G, Beil D, Huppert P, Noe M, Kissler S, Leyendecker G. Adenomyosis in endometriosis - Prevalence and impact on fertility. Evidence from magnetic resonance imaging. Hum. Reprod. 20, 2309-2316 (2005)
9. Bazot M, Fiori O, Darai E. Adenomyosis in endometriosis - Prevalence and impact on fertility. Evidence from magnetic resonance imaging. Hum. Reprod. 21, 1101-1102 (2006)
10. Quinn MJ, Kirk N. Differences in uterine innervation at hysterectomy. Am. J. Obstet. Gynecol. 187, 1515-1519 (2002)
11. Quinn M. Uterine innervation in adenomyosis. J. Obstet. Gynaecol. 7, 287-291 (2007)
12. Tokushige N, Markham R, Russell P, Fraser IS. High density of small nerve fibres in the functional layer of the endometrium in women with endometriosis. Hum. Reprod. 21, 782-787 (2006)
13. Tokushige N, Markham R, Russell P, Fraser IS. Different types of small nerve fibres in eutopic endometrium and myometrium in women with endometriosis. Fertil. Steril. 88, 795-803 (2007)
14. Zhang X, Lu B, Huang X, Xu H, Zhou C, Lin J. Endometrial nerve fibers in women with endometriosis, adenomyosis, and uterine fibroids. Fertil. Steril. 92, 1799-1801 (2009)
15. Zhang X, Lu B, Huang X, Xu H, Zhou C, Lin J. Innervation of endometrium and myometrium in women with painful adenomyosis and uterine fibroids. Fertil. Steril. 94, 730-737 (2010)
16. Kohnen G, Campbell S, Jeffers MD, Cameron IT. Spatially regulated differentiation of endometrial vascular smooth muscle cells. Hum. Reprod. 15, 284-292 (2000)
17. Tokyol C, Aktepe F, Dilek FH, Sahin O, Arioz DT. Expression of cyclo-oxygenase-2 and matrix metalloproteinase-2 in adenomyosis and endometrial polyps and its correlation with angiogenesis. Int. J. Gynecol. Pathol. 28, 148-156 (2009)
18. Bruner KL, Matrisian LM, Rodgers WH, Gorstein F, Osteen KG. Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. J. Clin. Invest. 99, 2851-2857 (1997)
19. Qiu F, Gao XM, Luo GL et al. [Expression of matrix metalloproteinase and tissue inhibitor of metalloproteinase in adenomyosis.] Sichuan Da Xue Xue Bao Yi Xue Ban 37, 118-122 (2006)
20. Li T, Li YG, Pu DM. Matrix metalloproteinase-2 and -9 expression correlated with angiogenesis in human adenomyosis. Gynecol. Obstet. Invest. 62, 229-235 (2006)
21. Goteri G, Lucarini G, Montik N et al. Expression of vascular endothelial growth factor (VEGF), hypoxia inducible factor-1a (HIF-1a), and microvessel density in endometrial tissue in women with adenomyosis. Int. J. Gynecol. Pathol. 28(2), 157-163 (2009)
22. Kang S, Zhao J, Liu Q, Zhou R, Wang N, Li Y. Vascular endothelial growth factor gene polymorphisms are associated with the risk of developing adenomyosis. Environ. Mol. Mutagen. 50, 361-366 (2009)
23. Jones RK, Searle RF, Bulmer JN. Apoptosis and bcl 2 expression in normal human endometrium, endometriosis and adenomyosis. Hum. Reprod. 13, 3496-3502 (1998)
24. Yang JH, Wu MY, Chen CD, Chen MJ, Yang YS, Ho HN. Altered apoptosis and proliferation in endometrial stromal cells of women with adenomyosis. Hum. Reprod. 22, 945-952 (2007)
25. Matsumoto Y, Iwasaka T, Yamasaki F, Sugimori H. Apoptosis and Ki-67 expression in adenomyotic lesions and in the corresponding eutopic endometrium. Obstet. Gynecol. 94, 71-77 (1999)
26. Yamamoto T, Noguchi T, Tamura T, Kitawaki J, Okada H. Evidence for estrogen synthesis in adenomyotic tissues. Am. J. Obstet. Gynecol. 169, 734-738 (1993)
27. Lei ZM, Rao CV, Lincoln SR, Ackermann DM. Increased expression of human chorionic gonadotropin/human luteinizing hormone receptors in adenomyosis. J. Clin. Endocrinol. Metab. 76, 763-768 (1993)
28. Nie J, Lu Y, Liu X, Guo SW. Immunoreactivity of progesterone receptor isoform B, nuclear factor kB, and IkBa in adenomyosis. Fertil. Steril. 92, 886-889 (2009)
29. Sotnikova N, Antsiferova I, Malyshkina A. Cytokine network of eutopic and ectopic endometrium in women with adenomyosis. Am. J. Reprod. Immunol. 47, 251-255 (2002)
30. Ota H, Igarashi S. Expression of major histocompatibility complex class II antigen in endometriotic tissue in patients with endometriosis and adenomyosis. Fertil. Steril. 60, 834-838 (1993)
31. Ota H, Igarashi S, Tanaka T. Expression of gdT cells and adhesion molecules in endometriotic tissue in patients with endometriosis and adenomyosis. Am. J. Reprod. Immunol. 35, 477-482 (1996)
32. Chiang CM, Hill JA. Localization of T cells, interferon-g and HLA-DR in eutopic and ectopic human endometrium. Gynecol. Obstet. Invest. 43, 245-250 (1997)
33. Ota H, Tanaka T. Integrin, adhesion molecules in the endometrial glandular epithelium in patients with endometriosis or adenomyosis. J. Obstet. Gynaecol. Res. 23, 485-491 (1997)
34. Ota H, Igarashi S, Hatazawa J, Tanaka T. Distribution of heat shock proteins in eutopic and ectopic endometrium in endometriosis and adenomyosis. Fertil. Steril. 68, 23-28 (1997)
35. Propst AM, Quade BJ, Nowak RA, Stewart EA. Granulocyte macrophage colony-stimulating factor in adenomyosis and autologous endometrium. J. Soc. Gynecol. Invest. 9, 93-97 (2002)
36. Wang F, Wen Z, Li H, Yang Z, Zhao X, Yao X. Human leukocyte antigen-G is expressed by the eutopic and ectopic endometrium of adenomyosis. Fertil. Steril. 90, 1599-1604 (2008)
37. Ota H, Igarashi S, Kato N, Tanaka T. Aberrant expression of glutathione peroxidase in eutopic and ectopic endometrium in endometriosis and adenomyosis. Fertil. Steril. 74, 313-318 (2000)
38. Ota H, Igarashi S, Tanaka T. Xanthine oxidase in eutopic and ectopic endometrium in endometriosis and adenomyosis. Fertil. Steril. 75, 785-790 (2001)
39. Ota H, Igarashi S, Sasaki M, Tanaka T. Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Hum. Reprod. 16, 561-566 (2001)
40. Ota H, Igarashi S, Hatazawa J, Tanaka T. Immunohistochemical assessment of superoxide dismutase expression in the endometrium in endometriosis and adenomyosis. Fertil. Steril. 72, 129-134 (1999)
41. Ota H, Igarashi S, Sato N, Tanaka H, Tanaka T. Involvement of catalase in the endometrium of patients with endometriosis and adenomyosis. Fertil. Steril. 78, 804-809 (2002)
42. Kitawaki J. Adenomyosis: The pathophysiology of an oestrogen-dependent disease. Best. Prac. Res. Clin. Obstet. Gynaecol. 20, 493-502 (2006)
43. Benagiano G, Brosens I, Carrara S. Adenomyosis: New knowledge is generating new treatment options. Womens Health (Lond. Engl.). 5, 297-311 (2009)
44. Maia H Jr, Casoy J, Correia T et al. Effect of the menstrual cycle and oral contraceptives on aromatase and cyclooxygenase-2 expression in adenomyosis. Gynecol. Endocrinol. 22, 547-551 (2006)
45. Chen YJ, Li HY, Huang CH et al. Oestrogen-induced epithelial-mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis J. Pathol. 222, 261-270 (2010)
46. Hatok J, Zubor P, Galo S et al. Endometrial aromatase mRNA as a possible screening tool for advanced endometriosis and adenomyosis. Gynecol. Endocrinol. 27, 331-336 (2011)
47. Nie J, Liu X, Guo SW. Immunoreactivity of oxytocin receptor and transient receptor potential vanilloid type 1 and its correlation with dysmenorrhea in adenomyosis. Am. J. Obstet. Gynecol. 202(4), 346.e1-8 (2010)
48. Cristino L, De Petrocellis L, Pryce G, Baker D, Guglielmotti V, Di Marzo V Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience 139, 1405-1415 (2006)
49. Khan KN, Kitajima M, Hiraki K et al. Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy. Hum. Reprod. 25, 642-653 (2010)
50. Khan KN, Kitajima M, Hiraki K et al. Cell proliferation effect of GnRH agonist on pathological lesions of women with endometriosis, adenomyosis and uterine myoma. Hum. Reprod. 25, 2878-2890 (2010)
51. Yang JH, Chen MJ, Wu MY, Chen YC, Yang YS, Ho HN. Decreased suppression of interleukin-6 after treatment with medroxyprogesterone acetate and danazol in endometrial stromal cells of women with adenomyosis. Fertil. Steril. 86, 1459-1465 (2006)
52. Mehasseb MK, Panchal R, Taylor AH, Brown L, Bell SC, Habiba M. Estrogen and progesterone receptor isoform distribution through the menstrual cycle in uteri with and without adenomyosis. Fertil. Steril. 95, 2228-2235 (2011)
53. Nie J, Liu X, Guo SW. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in adenomyosis and its rectification by a histone deacetylase inhibitor and a demethylation agent Reprod. Sci. 17, 995-1005 (2010)
54. Nie J, Lu Y, Liu X, Guo SW. Immunoreactivity of progesterone receptor isoform B, nuclear factor kB, and IkBa in adenomyosis. Fertil. Steril. 92, 886-889 (2009)
55. Shen F, Liu X, Geng JG, Guo SW. Increased immunoreactivity to SLIT/ROBO1 in ovarian endometriomas: A likely constituent biomarker for recurrence. Am. J. Pathol. 175, 479-488 (2009)
56. Nie J, Liu X, Zheng Y, Geng JG, Guo SW. Increased immunoreactivity to SLIT/ROBO1 and its correlation with severity of dysmenorrhea in adenomyosis. Fertil. Steril. 95, 1164-1167 (2011)
57. Liu X, Nie J, Guo SW. Elevated immunoreactivity to tissue factor and its association with dysmenorrhea severity and the amount of menses in adenomyosis. Hum. Reprod. 26, 337-345 (2011)
58. Huang YQ, Zheng W, Mu L et al. Expression of tyrosine kinase receptor B in eutopic endometrium of women with adenomyosis. Arch. Gynecol. Obstet. 283, 775-780 (2011)
59. Campo S, Campo V, Benagiano G. Infertility and adenomyosis. Reprod. Biomed. Online 24, 35-46 (2012)
60. Hever A, Roth RB, Hevezi PA et al. Molecular characterization of human adenomyosis. Mol. Hum. Reprod. 12, 737-748 (2006)
61. Brosens I, Kung G, Benagiano G. Is adenomyosis the neglected phenotype of an endomyometrial dysfunction syndrome? Gynecol. Surg. doi:10.1007/s10397-011- 0723- 3 (2012) (Epub ahead of print)
62. Kennedy S, Hadfield R, Westbrook C, Weeks DE, Barlow D, Golding S. Magnetic resonance imaging to assess familial risk in relatives of women with endometriosis. Lancet 352(9138), 1440-1441 (1998)